Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hormones and drugs that control blood pressure also control malaria infection

19.09.2003


Hormones that regulate cardiovascular function have been discovered to influence malaria infection. As a consequence, beta-blockers, which are safe, inexpensive and commonly prescribed drugs used worldwide to treat high blood pressure, are effective against the deadliest and most drug-resistant strain of malaria parasites.


These findings, by Kasturi Haldar, Jon Lomasney, Travis Harrison and colleagues at the Feinberg School of Medicine at Northwestern University, were reported in an article in the Sept. 19 issue of the journal Science.

Rather than targeting the parasite that causes malaria, an approach that has resulted in mounting resistance to a variety of antimalarial drugs, Haldar and co-researchers focused instead on identifying and blocking the process by which red blood cells allow parasite entry.

Haldar is Charles E. and Emma H. Morrison Professor in Pathology and professor of microbiology-immunology at the Feinberg School.



Malaria is a blood-borne illness transmitted by mosquitoes. Forty percent of the world’s population lives at risk for infection and between 200 and 300 million people are afflicted each year, particularly in underdeveloped and impoverished tropical and sub-Saharan countries.

The most virulent form of the four human malaria parasite species, Plasmodium falciparum, kills over 1 million children each year and is responsible for 25 percent of the infant mortality in Africa, according to latest estimates by the World Health Organization. Recently, however, P. falciparum also has been confirmed as the cause of over 50 cases of malaria among the 625 U.S. troops sent into Liberia. Another strain of malaria, P. vivax, has been confirmed in seven cases in Florida.

World wide there has been a resurgence of malaria in recent years, due mainly to the parasite’s growing resistance to drugs and the mosquito’s acquired resistance to insecticides developed to control the spread of the disease.

Athough malaria infects both liver and blood cells, it is during the “blood stage” of malaria -- when infected red blood cells that are “incubating” thousands of parasites literally explode and release more parasites into the blood stream -- that the symptoms of malaria occur. These symptoms include fever and flu-like symptoms such as chills, headache, muscle aches and fatigue. Immunity is slow to develop, and left untreated, malaria may be fatal, taking its greatest toll in children.

Blocking blood-stage infection by preventing the entry of the P. falciparum parasite into red blood cells provides the most direct way to control infection and quell the symptoms of malaria. But how red blood cells allow the entry of malaria parasites was unknown.

Travis Harrison, who is first author on the article and a research assistant in Haldar’s laboratory, found that G proteins in the red blood cell may be used by the parasite.

G proteins are essentially “go-betweens,” or transducers, that translate signals from hormones, neurotransmitters and other substances and in turn activate such cell processes as gene transcription, motility, secretion and contractility. G proteins have been intensively studied in a wide range of cells, but their functions in oxygen-carrying red blood cells are only beginning to be understood, Haldar said.

Research by Haldar and co-investigators showed that a G protein subunit, called Gs, concentrates around the malaria parasite during infection of the red blood cell.

Using special peptides, compounds similar to proteins, that inhibited the interaction of Gs protein, the researchers were able to show in several laboratory models of malaria that blocking the Gs signal resulted in decreased malaria infection.

Two major Gs-associated receptors, the beta-adrenergic and the adenosine receptors, are known to be present in red blood cells. Stimulating these receptors with a drug called an agonist increased infection of P. falciparum, while beta-blockers, which are antagonists, prevented the P. falciparum parasite from entering red blood cells.

“The use of beta-receptor antagonists, such as those already used to treat high blood pressure, may provide new approaches for treating malaria. Since beta-blockers are directed against a host target, there is low chance of rapid emergence of resistance to these drugs. Moreover, they may be used in combination therapy with existing drugs against parasite targets,” Lomasney and Haldar said.

“This finding offers the opportunity to use well-characterized, inexpensive drugs for a new, much-need application and the impetus for the development of new beta-blockers and other drugs to be tested for effectiveness against malaria,” they said.

Haldar’s co-authors on this study were Travis Harrison, Benjamin U. Samuel, and Thomas Akompong, departments of pathology and of microbiology-immunology, Feinberg School of Medicine; Heidi Hamm, Vanderbilt University, Nashville; Narla Mohandas, New York Blood Center, New York; and Jon W. Lomasney professor of pathology, Feinberg School of Medicine.



Grants from the National Institutes of Health supported this study.

KEYWORDS: malaria, Plasmodium falciparum, G protein, beta-blockers

CONTACT: Elizabeth Crown at (312) 503-8928 or at e-crown@northwestern.edu
Broadcast Media: Tamara Kerrill at (847) 491-4888 or tlk@northwestern.edu

Elizabeth Crown | EurekAlert!
Further information:
http://www.nwu.edu/

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

Why might reading make myopic?

18.07.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>